title: [andomized MRC RT01 trial of 64 Gy vs. 74 Gy in localized primary prostate cancer: Significant improvement in biochemical control, but still no significant improvement in long-term survival].
authors.forename: Gregor
authors.initials: G
authors.lastname: Goldner
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D020266:Radiotherapy, Conformal